HOME
Hepatitis B
Hepatitis C
HIV and AIDS
HIV-HCV Coinfection
HIV-HBV Coinfection
Hepatitis B Main Section
FDA-approved Treatments
Experimental Treatments
HBV Articles by Topic
HEPATITIS B THERAPIES CHART
FDA-approved Hepatitis B Treatments
Intron A (interferon alfa-2b)
(Intron A)
is given by injection several times a week for six months to a year, or sometimes longer. The drug can cause side effects such as flu-like symptoms, depression, and headaches. Approved 1991 and available only for adults.
Pegasys (peginterferon alfa-2a)
(Pegasys)
is given by injection once a week usually for six months to a year. The drug can cause side effects such as flu-like symptoms and depression. Approved May 2005 and available only for adults.
Epivir-HBV (lamivudine; 3TC)
(Epivir-HBV, Zeffix, or Heptodin) is a pill that is taken once a day, with few side effects, for at least one year or longer. Approved 1998 and available for both children and adults.
Hepsera (adefovir dipivoxil)
(Hepsera) is a pill taken once a day, with few side effects, for at least one year or longer. Approved September 2002 for adults. Pediatric clinical trials are in progress.
Baraclude (entecavir)
(Baraclude) is a pill taken once a day, with few side effects, for at least one year or longer. Approved April 2005 for adults. Pediatric clinical trials are in progress.
Tyzeka (telbivudine)
(Tyzeka, Sebivo) is a pill taken once a day, with few side effects, for at least one year or longer. Approved October 2006 for adults.
Experimental Hepatitis B Treatments
DRUG NAMECOMPANYSTATUS
Emtricitabine
(FTC)
Gilead
Foster City, CA
Phase III
Clevudine
(L-FMAU)
Pharmasset
Princeton, NJ
Phase III, US (2006)
Viread
(Tenofovir)
Gilead
Foster City, CA
Approved in Europe; Phase III in US
Valtorcitabine
(monoval LdC)
Idenix
Cambridge, MA
Phase II
Amdoxovir
(DAPD)
RFS Pharm LLC
Tucker, GA
Phase II
ANA 380 
(LB80380)
Anadys
San Diego, CA
Phase II
Pradefovir
(Remofovir)
Metabasis
San Diego, CA
with Valeant
Phase II

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HBV Articles on
FDA-approved Therapies
for Chronic HBV Infection

Baraclude  (entecavir)
Epivir-HBV  (lamivudine; 3TC)
Hepsera
  (adefovir dipivoxil)
Intron A
  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
Tyzeka   (telbivudine)